RespireRx Pharmaceuticals Inc.
OTC: RSPI0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Arnold S. Lippa
- Employees
- 2
- Headquarters
- Glen Rock, United States
- IPO year
- 1989
- Market cap
- $657.8K
- Website
- https://www.respirerx.com
Loading RSPI…
Loading profile data…Frequently asked questions about RSPI
What does RespireRx Pharmaceuticals Inc. (RSPI) do?
RespireRx Pharmaceuticals Inc. is dedicated to researching, developing, and commercializing pharmaceutical products aimed at addressing neurological and psychiatric conditions. The company operates through two primary therapeutic platforms: ResolutionRx, which investigates pharmaceutical cannabinoids, and EndeavourRx, focused on neuromodulators....
Where does RSPI trade?
RespireRx Pharmaceuticals Inc. (RSPI) trades on the Other OTC.
What sector is RSPI in?
RespireRx Pharmaceuticals Inc. (RSPI) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of RespireRx Pharmaceuticals Inc.?
Arnold S. Lippa is the chief executive officer of RespireRx Pharmaceuticals Inc. (RSPI).
Where is RespireRx Pharmaceuticals Inc. headquartered?
RespireRx Pharmaceuticals Inc. is headquartered in United States.
Does RSPI pay a dividend?
RespireRx Pharmaceuticals Inc. (RSPI) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did RSPI go public?
RespireRx Pharmaceuticals Inc. (RSPI) completed its initial public offering in 1989.